The Week in Cannabis: Coca-Cola Bows Out, Thailand Jumps In and States Vote for the Future
Entire Cannabis Industry Wins with Lawsuit Verdict in Favor of Colorado GrowerA long-brewing lawsuit that carried heavy implications for the cannabis industry as a whole came to a head this week when a federal judge ruled in favor of defendant Canna Craft Grow House. The cannabis grower was being sued by Meadows Legacy Horse Ranch, situated a quarter mile from the growery. They claimed that strong odors drifting from the growery were infringing on their rights and devaluing their property. While this may seem like a neighborly dispute at face value, the owners of the Colorado horse ranch were allowed to proceed with the lawsuit with regulations based in the RICO Act, tying the cannabis industry to racketeering. It was an oddly close call for the industry as a whole, since a win for the horse ranch threatened to open a Pandora’s box of similar lawsuits aimed at other cannabis industry businesses.
Will Thailand Be the First Asian Country to Legalize Medical Cannabis?
Coca-Cola CBD Drinks Aren’t Coming Anytime SoonMeanwhile, The Coca-Cola Company is pumping the brakes on adding cannabis-based ingredients to beverages in the near future. Though it was reported at the end of September that Coca-Cola were exploring interests in cannabis beverages, CEO James Quincey clarified this week that the company has no plans to pursue these interests until science catches up with legalization and ingredients pulled from the herb are deemed safe for consumption. Until Quincey’s statement, it was thought that Coca-Cola were exploring the idea of adding CBD to certain beverages.
The First Cannabis-Based Medication to Get FDA Approval
Though we’re still awaiting the federal government to get with the program when it comes to naturally-occurring cannabis, the FDA made history this week by approving a cannabis-based drug for sale in all 50 U.S. states. Epidiolex is an orally administered medication designed to treat certain types of epilepsy in patients age 2-years and older. Of course, the genuine article is probably a safer bet, but for patients in the hold-out states that have yet to legalize medical use cannabis, this may be the closest they get to relief for the time being.